Showing results (131-140 of 169) with videos related to

Sort By:
Pageof 17
Cancer Discovery|August 30, 2018
<i>In Situ</i> Vaccination with a TLR9 Agonist and Local Low-Dose Radiation Induces Systemic Responses in Untreated Indolent LymphomaMatthew J Frank, Patrick M Reagan, Nancy L Bartlett, et al.
Cancer Immunology Research|January 20, 2019
TIGIT and PD-1 Mark Intratumoral T Cells with Reduced Effector Function in B-cell Non-Hodgkin LymphomaSarah E Josefsson, Klaus Beiske, Yngvild N Blaker, et al.
Blood|January 9, 2013
Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphomaMichael R Green, Andrew J Gentles, Ramesh V Nair, et al.
The Journal of Clinical Investigation|February 14, 2012
Stimulation of natural killer cells with a CD137-specific antibody enhances trastuzumab efficacy in xenotransplant models of breast cancerHolbrook E Kohrt, Roch Houot, Kipp Weiskopf, et al.
Nature Biotechnology|October 16, 2019
Predicting HLA class II antigen presentation through integrated deep learningBinbin Chen, Michael S Khodadoust, Niclas Olsson, et al.
Blood|December 25, 2016
Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profilingJune H Myklebust, Joshua Brody, Holbrook E Kohrt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2010
In situ vaccination with a TLR9 agonist induces systemic lymphoma regression: a phase I/II studyJoshua D Brody, Weiyun Z Ai, Debra K Czerwinski, et al.
The Journal of Clinical Investigation|June 4, 2013
Depleting tumor-specific Tregs at a single site eradicates disseminated tumorsAurélien Marabelle, Holbrook Kohrt, Idit Sagiv-Barfi, et al.
Pageof 17